Drug-discovery-and-development.pharmatechoutlook.com
Visit drug-discovery-and-development.pharmatechoutlook.comBest Drug Discovery and Development Process - Strategies - Practices | Pharma Tech Outlook
Global rank | 782 099 |
---|---|
Daily visitors | 25 |
Daily pageviews | 25 |
Pageviews per user | 1 |
Rating | |
---|---|
Status | Online |
Latest check |
Countable Data Brief
Pharmatechoutlook.com is tracked by us since November, 2015. Over the time it has been ranked as high as 164 099 in the world, while most of its traffic comes from USA, where it reached as high as 100 167 position. Drug-discovery-and-development.pharmatechoutlook.com receives about 2.31% of its total traffic. It was hosted by Amazon Technologies Inc.. While GODADDY.COM LLC was its first registrar, now it is moved to GoDaddy.com LLC.
Drug-discovery-and-development.pharmatechoutlook has the lowest Google pagerank and bad results in terms of Yandex topical citation index. We found that Drug-discovery-and-development.pharmatechoutlook.com is poorly ‘socialized’ in respect to any social network. According to Siteadvisor and Google safe browsing analytics, Drug-discovery-and-development.pharmatechoutlook.com is quite a safe domain with no visitor reviews.
Worldwide Audience
Compare it to ...Pharmatechoutlook.com gets 79.04% of its traffic from USA where it is ranked #125719.
Top Countries
USA | 79.0% | |
Austria | 2.9% | |
United Kingdom | 2.5% | |
Netherlands | 1.6% | |
Germany | 1.4% |
Top Ranks
Austria | 86 711 | |
USA | 125 719 | |
Germany | 306 131 | |
Netherlands | 363 733 | |
United Kingdom | 365 870 |
Traffic Analysis
Compare it to ...Drug-discovery-and-development.pharmatechoutlook.com has 25 visitors and 25 pageviews daily.
Pageviews
Subdomains Traffic Shares
Pharmacovigilance.pharmatechoutlook.com is the most popular subdomain of Pharmatechoutlook.com with 5.05% of its total traffic.
Top Subdomains
pharmacovigilance.pharmatechoutlook.com | 5.05% | |
enterprise-software.pharmatechoutlook.com | 4.88% | |
europe.pharmatechoutlook.com | 4.33% | |
biotech-startup.pharmatechoutlook.com | 3.86% | |
other | 43.89% |
This Subdomain
SEO Stats
Compare it to ...Drug-discovery-and-development.pharmatechoutlook.com is not yet effective in its SEO tactics: it has Google PR 0. It may also be penalized or lacking valuable inbound links.
0
Google PR-
Yandex CYMetadata Updates Get more Drug-discovery-and-development.pharmatechoutlook.com metadata updates
Homepage Top Backlinks PR
No data
Top Keywords % of search traffic
No data
Domain Registration Data
Compare it to ...Drug-discovery-and-development.pharmatechoutlook.com domain is owned by Registration Private Domains By Proxy, LLC and its registration expires in 1 month.
General Get more Pharmatechoutlook.com whois history
Registration Private Domains By Proxy, LLC Owner since April 13, 2022 |
||
---|---|---|
1 month left Expires on January 08, 2025 |
10 years old Created on January 08, 2014 |
10 months ago Changed at January 09, 2024 |
Server Information
Compare it to ...Drug-discovery-and-development.pharmatechoutlook.com is hosted by Amazon Technologies Inc.
IP Whois Get more Drug-discovery-and-development.pharmatechoutlook.com server history
-
Amazon Technologies Inc.
-
52.33.124.163
IP address
Server Technologies
-
Apache HTTP Server
Backend server
DNS Records
Nameservers
No data
host | value | ttl |
---|---|---|
drug-discovery-and-development.pharmatechoutlook.com | 52.33.124.163 |
300 |
Safety
Compare it to ...Safety status of Drug-discovery-and-development.pharmatechoutlook.com is described as follows: Google Safe Browsing reports its status as safe.
MyWOT
Overall reputation | Unknown |
---|---|
Trustworthiness | Unknown |
Privacy | Unknown |
Child safety | Unknown |
Google Safe Browsing
Website status | Safe |
---|---|
Status | ok |
User reviews
Reputation | Unknown | |
---|---|---|
0 positive0 negative |
Social Engagement
Compare it to ...It seems Drug-discovery-and-development.pharmatechoutlook.com has no mentions in social networks.